GS87 is a highly specific and potent GSK3 inhibitor with IC50s of 415nM and 521nM for GSK3alpha and GSK3beta, respectively. GS87 induces differentiation of acute myeloid leukemia (AML) cell lines by effectively activating GSK3-dependent signaling components including MAPK signaling. GS87 modulates key GSK3 target proteins involved in cell proliferation and differentiation more effectively than Lithium and SB415285 (SB). GS87 has the potential for acting as a differentiation agent for non-promyelocytic AML research[1].
Molecular Weight:
337.36
Purity:
99.81
CAS Number:
[919936-70-2]
Formula:
C16H11N5O2S
Target:
GSK-3
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
